Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281463 · ClinicalTrials.gov registry record · NA
Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia
A NA study, sponsored by VA Pittsburgh Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00281463 is a NA study that has completed, run by VA Pittsburgh Healthcare System. The registered enrollment target is 45 participants.
The verdict
NCT00281463, a NA study, has completed, sponsored by VA Pittsburgh Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair users will evaluate the PAPAW over activities of daily living course to determine its usability and acceptability and to identify areas for future development. Finally, in phase III, comparison of activities of daily living in the community will be made between the subjects when using their personal wheelchair and a PAPAW.
Interventions
- DEVICE Pushrim Activated Power Assist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2001-11 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281463
The ClinicalTrials.gov registry entry for NCT00281463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Pittsburgh Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pushrim Activated Power Assist is the first listed.
NCT00281463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281463 about?
NCT00281463 is a clinical study titled "Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia". The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair...
What is the current status of trial NCT00281463?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2001-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00281463?
The interventions under investigation include: Pushrim Activated Power Assist (DEVICE).
Who is sponsoring clinical trial NCT00281463?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.